Patents by Inventor Anne B. Eldrup

Anne B. Eldrup has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide nucleic acid monomers and oligomers
    Patent number: 6632919
    Abstract: Novel peptide nucleic acid (PNA) oligomers and their constituent monomers are disclosed. The PNA oligomers and linked PNAs form triple stranded structures with nucleic acids that show an increased specificity for thymidine in nucleic acid targets relative to naturally occurring nucleobases.
    Type: Grant
    Filed: May 22, 1998
    Date of Patent: October 14, 2003
    Inventors: Peter E. Nielsen, Gerald Haaima, Anne B. Eldrup
  • Peptide nucleic acid monomers and oligomers
    Patent number: 6617422
    Abstract: Novel peptide nucleic acid (PNA) oligomers and their constituent monomers are disclosed. The PNA oligomers and linked PNAs form triple stranded structures with nucleic acids that show an increased specificity for thymidine in nucleic acid targets relative to naturally occurring nucleobases.
    Type: Grant
    Filed: May 23, 1997
    Date of Patent: September 9, 2003
    Inventors: Peter E. Nielsen, Gerald Haaima, Anne B. Eldrup
  • Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
    Publication number: 20020147160
    Abstract: The present invention provides nucleoside compounds and certain derivatives thereof which are inhibitors of RNA-dependent RNA viral polymerase. These compounds are inhibitors of RNA-dependent RNA viral replication and are useful for the treatment of RNA-dependent RNA viral infection. They are particularly useful as inhibitors of hepatitis C virus (HCV) NS5B polymerase, as inhibitors of HCV replication, and/or for the treatment of hepatitis C infection. The invention also describes pharmaceutical compositions containing such nucleoside compounds alone or in combination with other agents active against RNA-dependent RNA viral infection, in particular HCV infection. Also disclosed are methods of inhibiting RNA-dependent RNA polymerase, inhibiting RNA-dependent RNA viral replication, and/or treating RNA-dependent RNA viral infection with the nucleoside compounds of the present invention.
    Type: Application
    Filed: January 18, 2002
    Publication date: October 10, 2002
    Inventors: Balkrishen Bhat, Neelima Bhat, Anne B. Eldrup, Thazha P. Prakash, Marija Prhavc, Quanlai Song, Phillip Dan Cook, Steven S. Carroll, Malcolm Maccoss, David B. Olsen